
Opinion|Videos|September 13, 2024
Cost Considerations With Intravenous and Subcutaneous Biologics
Author(s)Jennifer Seminerio, MD
Key topics in cost of intravenous and subcutaneous biologics are discussed by Dr Seminerio.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do you evaluate the costs between IV vs. subQ therapies when deciding which route of administration to use in patients?
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves Lipfendra, first oral PCSK9 inhibitor
2
How the most favored nation drug pricing policy is quietly reshaping drug development and clinical research
3
Capital Rx is now Judi Rx in a company rebrand
4
FTC secures settlement with Caremark, locks in up to $8.5 billion in consumer savings
5

























